Ribonucleic acid-based therapy for Myocardial Infarction: LncRNA 015192 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up-regulation of PNUTS, 16/January/2019, 1.00 pm